©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 109980
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109980
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109980
Figure 7 Most common adverse event.
The most common 15 adverse event were displayed and the horizontal axis represents person-time, which display the frequency in each group.
- Citation: Qin X, Chen J, Zhang HN, Du L, Ma Y, Li Y, Lu Y, Wang YT, Wu LF, Yu ZH, Hu MJ, Li LJ, Liao B, Li Z, Yang ZY, Li K, Yuan YF. Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial. World J Gastrointest Surg 2025; 17(9): 109980
- URL: https://www.wjgnet.com/1948-9366/full/v17/i9/109980.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i9.109980